Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has submitted a routine compliance certificate to the exchanges for the quarter ended June 30, 2025. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent (RTA). It confirms that all physical share certificates received for dematerialisation during the quarter were properly verified, accepted or rejected by the depositories, and the corresponding entries were updated in the company's register of members. This is a standard quarterly regulatory filing required under SEBI's Depositories and Participants Regulations, 2018.
This is a routine compliance disclosure with no material impact on the company's financials, operations, or stock price. It is purely an administrative confirmation that the company's share transfer process is functioning normally.